Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-12
2007-06-12
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S106000
Reexamination Certificate
active
10297592
ABSTRACT:
(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[2-[(2S)-2-(methoxymethyl)morpholino]ethyl]-2-(3-hydroxy-4-methylbenzyl)piperazine dihydrochloride is obtained by debenzylating (2R)-4-benzyl-1-[3,5-bis(trifluoromethyl)-benzoyl]-2-(3-hydroxy-4-methylbenzyl)piperazine, then N-alkylating and converting to hydrochloride.
REFERENCES:
patent: 5670505 (1997-09-01), Matsuo et al.
patent: 5883098 (1999-03-01), Matsuo et al.
patent: 96/34864 (1996-11-01), None
patent: 97/08166 (1997-03-01), None
patent: 97/22597 (1997-06-01), None
patent: 98/57954 (1998-12-01), None
patent: WO 9857954 (1998-12-01), None
patent: 00/35915 (2000-06-01), None
patent: WO 200035915 (2000-06-01), None
Fujii Yosuke
Goto Shunsuke
Hirabayashi Satoshi
Koga Keiichi
Orii Ryoki
Astellas Pharma Inc.
Grazier Nyeemah
Saeed Kamal A.
LandOfFree
Process for the preparation of a piperazine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of a piperazine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of a piperazine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3877802